Development of Recombinant B7-H4-Ig Fusion Protein (AMP-110) as a Therapeutic Treatment for Multiple Sclerosis

Project: Research project

Project Details

StatusFinished
Effective start/end date2/24/102/23/17

Funding

  • Amplimmune, Inc. (Agmt 2/24/10 // Agmt 2/24/10)
  • Fast Forward, LLC (Agmt 2/24/10 // Agmt 2/24/10)